S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
Top 5 AI Stocks to Buy for 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Biden replacement revealed? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
Top 5 AI Stocks to Buy for 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Biden replacement revealed? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
Top 5 AI Stocks to Buy for 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Biden replacement revealed? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
Top 5 AI Stocks to Buy for 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Biden replacement revealed? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial

CRISPR Therapeutics (CRSP) Insider Trading & Ownership

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free crsp Stock Alerts
$56.16
+0.60 (+1.08%)
(As of 04/18/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

CRISPR Therapeutics (NASDAQ:CRSP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.10%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$13.30 M
Get CRSP Insider Trade Alerts

Want to know when executives and insiders are buying or selling CRISPR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CRSP Insider Buying and Selling by Quarter

Ad DTI
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Click here for the full story

CRISPR Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/15/2024Samarth KulkarniCEOSell19,582$59.91$1,173,157.62  
3/15/2024Raju PrasadCFOSell3,524$72.69$256,159.56  
3/15/2024Samarth KulkarniCEOSell20,000$72.48$1,449,600.00  
3/11/2024James R KasingerGeneral CounselSell2,801$78.26$219,206.26  
3/11/2024Samarth KulkarniCEOSell9,802$78.26$767,104.52  
2/20/2024James R KasingerGeneral CounselSell1,913$79.67$152,408.71  
2/20/2024Samarth KulkarniCEOSell6,370$79.67$507,497.90  
2/15/2024Samarth KulkarniCEOSell20,000$80.36$1,607,200.00  
1/29/2024Samarth KulkarniCEOSell50,000$60.51$3,025,500.00  
1/16/2024Samarth KulkarniCEOSell20,000$62.50$1,250,000.00  
5/30/2023Samarth KulkarniCEOSell25,000$64.88$1,622,000.00  
4/25/2023Samarth KulkarniCEOSell25,000$50.67$1,266,750.00  
(Data available from 1/1/2013 forward)

CRSP Insider Trading Activity - Frequently Asked Questions

Who is on CRISPR Therapeutics's Insider Roster?

The list of insiders at CRISPR Therapeutics includes Bradley J Phd Bolzon, James R Kasinger, Michael John Tomsicek, Raju Prasad, Rodger Novak, and Samarth Kulkarni. Learn more on insiders at CRSP.

What percentage of CRISPR Therapeutics stock is owned by insiders?

4.10% of CRISPR Therapeutics stock is owned by insiders. Learn more on CRSP's insider holdings.

Which CRISPR Therapeutics insiders have been selling company stock?

The following insiders have sold CRSP shares in the last 24 months: James R Kasinger ($371,614.97), Raju Prasad ($256,159.56), and Samarth Kulkarni ($26,741,310.04).

How much insider selling is happening at CRISPR Therapeutics?

Insiders have sold a total of 453,992 CRISPR Therapeutics shares in the last 24 months for a total of $27,369,084.57 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:CRSP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research